bladder cancer
E.C. Zwarthoff (Ellen)
Erasmus University Rotterdam
978-90-90-27179-8
hdl.handle.net/1765/38061
The research described in this thesis was performed at the Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, the Netherlands, and was  nancially supported by the following grants: Erasmus MC (MRACE 2007); European Community Seventh Framework program FP7/2007-2012, grant agreement no 201663; Dutch Cancer Society grant no. EMCR 2007-3863.The research described in this thesis was performed at the Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, the Netherlands, and was  nancially supported by the following grants: Erasmus MC (MRACE 2007); European Community Seventh Framework program FP7/2007-2012, grant agreement no 201663; Dutch Cancer Society grant no. EMCR 2007-3863.The research described in this thesis was performed at the Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, the Netherlands, and was financially supported by the following grants: Erasmus MC (MRACE 2007); European Community Seventh Framework program FP7/2007-2012, grant agreement no 201663; Dutch Cancer Society grant no. EMCR 2007-3863.
This work was funded by the European Commission 7th Framework Programme; grant id fp7/201663 - Prediction of bladder cancer disease course using risk scores that combine molecular and clinical risk factors (UROMOL)
Erasmus MC: University Medical Center Rotterdam

Kandimalla, R. (2012, December 12). Genome-Wide DNA methylation profiling in Bladder cancer and identification of diagnostic and prognostic markers. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/38061